CVS vs. Walgreens | Trouble Behind the Counter | 5

8 Nov 2023 · 42 min

Ask about this episode

Ask anything about it. ChatGPT or Claude reads this page and answers with the times it was said.

Connect VO and ask about every podcast you hear, including the moments you saved. Add to ChatGPT · Add to Claude

In short

Business Wars Podcast Episode Summary

Podcast Title

Business Wars

Description

Business is war. Through various corporate battles, the podcast explores the dynamics between industry giants, what drives them, and the consequences for consumers. Hosted by David Brown, it provides an unauthorized look at the stories behind major businesses.

---

Episode Title

CVS vs. Walgreens | Trouble Behind the Counter | Episode 5

Episode Description

The episode delves into the ongoing struggles of pharmacies, addressing issues such as overworked pharmacists, healthcare consolidation, and rising drug costs. Guests include Dan Weissmann, who discusses the implications of big pharmacies on patients and Liz Tung, who investigates the role and impact of Pharmacy Benefit Managers (PBMs).

---

Key Themes and Discussions

  1. Current Landscape of Pharmacies
  2. Diverse Roles: Pharmacies like CVS and Walgreens have evolved to offer more than just medications; they now provide in-store clinics, flu shots, and COVID boosters.
  3. Healthcare Integration: The increasing consolidation in the healthcare sector has left patients and pharmacists feeling overwhelmed and under-supported.
  1. Challenges Faced by Pharmacies
  2. Staffing Issues: Reports of overworked pharmacists leading to long wait times and staff shortages.
  3. Walkouts: Employees at CVS and Walgreens are contemplating walkouts due to unmanageable workloads and stress.
  1. Independent Pharmacies vs. Chains
  2. Patient Experience: Many patients prefer independent pharmacies for personalized service and responsiveness.
  3. Financial Viability: Independent pharmacies face challenges due to PBM practices and competitive pricing pressures from large chains.
  1. The Role of Pharmacy Benefit Managers (PBMs)
  2. Definition: PBMs act as intermediaries between drug manufacturers, pharmacies, and insurance companies. They negotiate prices and manage drug benefits.
  3. Impact on Pricing: PBMs can obscure pricing structures, leading to confusion for consumers and pharmacists alike. They negotiate rebates from manufacturers that can drive up the list prices of drugs.
  1. Concerns Over PBM Practices
  2. Clawbacks and DIR Fees: Independent pharmacies report unpredictable clawbacks from PBMs that can severely impact their finances and operations.
  3. Lack of Transparency: Pharmacies feel they lack insight into PBM practices, making it difficult to navigate their financial landscape.
  1. Legislative Responses
  2. Calls for Reform: There is growing awareness and legislative interest in regulating PBM practices to ensure fairer pricing and transparency in drug pricing.

---

Key Takeaways

  • Patient Care: The challenges faced by pharmacies highlight significant issues in patient care coordination and access to medications.
  • Pharmacy Landscape Changes: A trend towards consolidation in the pharmacy sector raises questions about the future of independent pharmacies and their ability to compete.
  • PBM Influence: The increasing power of PBMs in the healthcare system poses potential risks for both consumers and independent pharmacies, necessitating scrutiny and possible reform.
  • Personal Experiences Matter: Individual stories from pharmacists and patients reveal the profound impact of pharmacy practices on everyday lives, emphasizing the need for systemic change.

---

Conclusion This episode of *Business Wars* offers an insightful examination of the evolving pharmacy landscape, focusing on the intricacies of patient care, the role of powerful intermediaries like PBMs, and the ongoing struggles of both chain and independent pharmacies in a rapidly changing healthcare environment.

Written by AI. May contain mistakes. Listen to the episode to check what was said.

Hear the part that matters, and keep it.Open this episode in VO. Double tap your headphones to save a moment as you listen.
Get VO free

Transcript

Automatic transcript. May contain errors.

0:06I'm David Brown and this is Business Wars.

0:29When you hear CVS and Walgreens, what do you think of? Maybe your mind goes straight to retail. aisles loaded with candy, beauty products, cheap holiday decor. You know what I'm talking about. Or perhaps you think about the in-store clinics where you can go see a doctor in a pinch or grab your flu shot or COVID booster. Well, today's pharmacies certainly look a lot different and wear a lot more hats than they once did. But as big pharmacies take over more of the healthcare industry, patients, providers, and pharmacists themselves are finding themselves tangled up in a confusing and costly web without much agency.

1:05Today's guests are here to help us make some sense of this constantly changing industry. First, we're speaking with Dan Weissman, host of the podcast, and Arm and a Leg, co-produced with KFF Health News. And as the big pharmacies become more monolithic in the world of health care, Dan will be breaking down what that means for patients across the U.S. Later, we'll be joined by Liz Tong, a reporter for WHYY's health and science podcast, The Pulse. She untangled some of this health care web to dive deeper into the mysterious pharmacy benefit managers who are shaping the cost of drugs for consumers and challenging independent pharmacies nationwide.

1:41All that's coming up.

1:47When planning for your future, you want someone with a history of keeping their word year after year. For nearly 160 years, Pacific Life has been a trusted name in the industry. But that isn't just a number. It's experience that matters. It's 160 years of promises held, helping generations retire with confidence, protect their loved ones, and plan for whatever comes next. Whether you're looking for life insurance, employee benefits, or retirement income solutions, when your future is on the line, you want history on your side. And believe me, Pacific Life has been there, always there through changing times, always focused on your needs.

2:26Ready to secure your tomorrow? Ask a financial professional how Pacific Life can help you feel prepared for what's next. Pacific Life Insurance Company, Omaha, Nebraska, and in New York, Pacific Life & Annuity, Phoenix, Arizona. Because with Pacific Life, you're not just planning for the future. You're partnering with trusted experience. Closing the books, getting your people paid, and bringing on new hires. Running a small or mid-sized business can be exciting and also a little chaotic. Workday Go makes simplifying your business, well, simple. Imagine all the important aspects of your company, HR, finance, and payroll, all on the AI platform.

3:08No more juggling multiple systems, no more worrying about growing too fast. Just the full power of Workday Go, helping small to mid-sized businesses like yours scale and run more smoothly. Think about what that means. Seamless onboarding for new team members, real-time insights at your fingertips, and payroll that works perfectly every single time. So you can focus on the big picture and go after your big ambitions. And with Workday, you can activate quickly in as little as 30 to 60 business days. So simplify your business. Go for growth. Go with Workday Go.

3:54Dan Weissman, welcome to Business Wars. Thanks so much for having me. Hey, tell us about your Arm and a Leg podcast. I understand it's about the high cost of health care and how we got there, but what inspired you to dive deep into health care costs? Oh, man, how long do you have? Yeah, Arm and a Leg is a show about why health care costs so freaking much, what we can maybe do about it. And honestly, it's an underwitnessed topic and a really important one in our society. As a reporter, I'd come across it, you know, and in my life I'd come across and I was like, we don't talk about this enough. And I, you know, I started talking to people about it.

4:29Initially, I thought it was going to be like, you know, there's a lot of horror stories out there. And a good friend of mine who's a really big pro was like, well, who's going to tune into that on purpose? That sounds very depressing. who's gonna tune in on purpose that's hilarious well she was super right um you know uh in the same conversation she was like you know i survived breast cancer last year and i'm still fighting with my insurance over the wig they didn't want to pay for and i was like wow that's incredible yeah well yeah and everybody that i talked to to ask him about my crazy idea was like well that's an interesting crazy idea did i tell you about this thing that happened to me and i was like oh I see this isn't just the stories the horror stories you see in the paper this is like actually happening to all of us right now um and I was like I think this might be a show well Dan of course pharmacy is a big part of health care and and and CVS and Walgreens specifically the focus of our latest business wars season which one of those two CVS Walgreens which one do you see more commonly in your area?

5:36Well, it's a super good question. You know, I grew up in Chicago. I still live here. And Walgreens is from Chicago. So when I grew up, it was all Walgreens out here. Then sometime in the last 20, 30 years, CBS bought one of the other big local chains. It was a chain called Osco. Oh, I remember Osco's. Sure. Yeah. And CBS bought Osco's. And so suddenly there were a bunch of CBS around. I was like, well, OK, cool. And apparently that's, you know, from kind of reading up, that's what they've done around the country. Right. And Walgreens also, they both both of those chains have like basically bought up lots and lots of the other kind of regional chains around the country.

6:15So there are now these kind of two big national behemoths. You know, I'm curious about whether or not you've experienced something like this, too. I went into a CVS recently and frankly, blown away by how long you had to wait in the line. I mean, there are just a couple of folks behind the counter. The drive-thru was closed. Kind of a pain, but I didn't know who was hurting worse, me or the staff, right? Right. This is a I mean, this is a problem. I think that everyone who has had to get a prescription filled has experienced in the last few years for sure. Yeah. In our family, like we got a couple of prescriptions that come around every month and we like call around to see who has what we need in stock.

6:55We like time our days. I'll tell you what we do now is we've found an independent pharmacy that answers the phone, which Walgreens and CVS basically don't. But you'll be on hold a long time, at least around the CVS and Walgreens around us. And they deliver. Huh. That's interesting. We pay them five bucks. That is fascinating. And you went to an independent, like, mom-and-pop style pharmacy? Yeah. Yeah. My wife found it. And I'm like, this is good. I really want to. Like, we want to keep these guys in business. We're going to have to put a pin in that because I know later in our program, we're going to be talking about these independent pharmacies and what they're up against.

7:32Of course, Walgreens employees are talking a lot about walkouts as a result of being overworked. And I should point out, you know, we're talking, we're having this conversation in mid-October. And by the time some of our listeners may hear this, things may have, all sorts of things may have transpired. We're hearing CVS employees may join in the walkout as well. What is going on here? Well, I remember in the early days of the pandemic reading about this, and certainly that's when I first remember the phenomenon of like, wow, the late times at the pharmacy are super long. I mean, everything was pretty bananas at that time.

8:11But but that's when I first started reading stories where pharmacists from Walgreens and CVS were complaining that basically they were being super overworked and that they and I remember seeing comments that they were like, it's not safe. Like they were basically they couldn't have faith that they were going to fill everybody's prescription correctly, which is kind of a high stakes problem. So, yeah. So that's, you know, three and a half years ago. So it's not I mean, it's been brewing for a long time. Well, now, what happens when pharmacy staff move forward with these walkouts? I mean, how are patients affected?

8:49I mean, well, gosh, like anybody listening to this will have a clearer answer than we do now. Right. Right. Because you will have lived through it. But if you're somebody who needs a prescription filled and the pharmacists have walked out, it's going to be kind of a big deal. Like, you know, not I mean, like people who take, for instance, medicine for ADHD have to get that prescription refilled like kind of by hand every month. It doesn't just automatically happen because it's a controlled substance in a lot of those medicines. So that's very time sensitive. And obviously, if you like, I don't know, you have strep throat, you need or you have some other bacterial infection, you need it treated right away.

9:30You need insulin. People can't live without that. I mean, let's go on. Right. If you have COVID-19 and need Paxlovid like that, you can't only take that in the first few days of being infected. So like if you can't get medicine from your pharmacy, that's going to be a problem. Well, you know, what you've observed about the way pharmacies are operating these days is it's I think it lines up with what we've seen when we go to the drugstore. It seems like they're much more than just places to pick up medication. I mean, some cases they can feel like full fledged doctor's offices, you know, with flu shots, boosters, minute clinic and all that.

10:07How common is that? Yeah, well, I mean, I'm in where I am. It's it's pretty common for the CVS to have a minute clinic inside it. And then they also operate these MinuteClinic stores inside of Target stores. And I'll tell you, it's more than once I've been in a situation where I'm like, I'm worried I might have strep throat. And I don't try calling my primary care doctor because that's, I mean, that's a big investment of time. And they'll be like, well, is this, you can go to some urgent care. You can do this. Like I've gone to MinuteClinic a bunch of times to get checked out because it works.

10:39You can make an appointment online, show up and, you know, talk to somebody. And frankly, last time I did, the nurse practitioner there engaged with me more and had a more substantive conversation with me than I've sometimes had with a doctor at my doctor's office. That's kind of amazing. Is the quality of care, where do you put it on a scale? Well, it's really hard to say. And I'm not an expert on the quality of care. But nurse practitioners get training. But they do not go through as much training as doctors do. You know, I kind of think I would prefer to have a doctor, you know, caring for me because they have had a ton more training and just seen a lot more things in their training.

11:25But I mean, it's part of a bigger trend, right, where we have a big lack of primary care docs in our country. And we could talk a lot about the economics of that. Primary care docs don't make as much as folks in other specialties. There's lots of disincentives for folks from medical school to go into it. It's really hard to operate your own primary care practice for some of those reasons because primary care docs don't get paid by insurance as much. And so they tend to get their practice often get bought up by big local hospital systems, which then erect a lot of barriers to care. In my experience, right, you want to see your doctor.

12:00You've got to make an appointment through my chart and maybe it's several weeks out. And there's a lot more paperwork to fill out because they have all of this infrastructure in the big health systems to make sure they get every single dollar that they can from you and from insurance. But I'm wondering where this is headed and where we actually stand. I wonder if, in a way, what we're talking about is a kind of restructuring of priorities and of health care in the U.S., where it's sort of shifting and the pharmacy is taking a much more prominent role in that puzzle than any of us really realize.

12:41I've been kind of starting to starting to get my bearings. It's only been at this for five years, and I feel like I'm starting to get my bearings in the world of health care. But just beginning. But that that basically every player seems to feel like they have an incentive to grow because basically all the other players are growing. So, you know, United Health Group is the biggest of the big. And they, among other things, their Optum subsidiary is now the biggest employer of physicians in the United States by a considerable amount. And this is something they've just gotten into in the last maybe 10 years in volume.

13:18But they employ like 70 ,000 physicians. And like the nearest competition, which would be like Kaiser Permanente on the West Coast, is at least at least 20 ,000 behind them. They're they're like two or three times bigger than the VA. It's a huge thing. And the whole thing is they're all feel like they're competing against these giant sharks. Right. Like if you're an insurance company, you're like, wow, all these big health provider chains have gotten so big. We have to negotiate with them. wouldn't it be better if we like got bigger ourselves and had more bargaining power with them or even employed our own physicians if you're a hospital chain you also are like well we have to negotiate with united and blue cross and all the others we want to be as big as possible so we're in the strongest possible bargaining position and if you're cvs i mean cvs is kind of ahead in in that game of what i guess i'd call consolidation i don't know what to call it um because they're It's not like they're just consolidating themselves as a drugstore entity.

14:17They're like, well, we went and bought Minute Clinic and we went and bought all of Target's in-store clinics. And we went and bought Caremark, which is the pharmacy benefit manager. We went and bought Aetna, the big insurance company. So they're trying to be everywhere and everything. And Walgreens, as far as I can tell, is doing less of that. I know there have been some leadership shakeups at Walgreens recently with a CEO leaving. Rite Aid, another competitor in this space, although considerably smaller than either CVS or Walgreens, they've been in some hot water, too. What's going on here? What does it say about the industry?

14:52As we speak, Rite Aid has just filed for bankruptcy, and that's kind of a big deal. It appears like they fell behind in this game of getting really big. And actually, a few years ago, apparently they tried to sell themselves entirely to Walgreens and federal regulators were like, that's a little too much consolidation. But they did sell like half of their stores to Walgreens. So, you know, according to the Wall Street analysts who get quoted in the news stories that I'm reading, you know, they they fell behind and they don't they when you're smaller, you have less negotiating power with all those other players, with the insurers and the pharmacy benefit managers and the drug makers.

15:30You know, let's let's talk more about the competition here, because we've got grocery stores with their own pharmacies, right? I mean, you've got Walmart, Wegmans, Albertsons, and then you've got e-commerce entering this game, too. What's your sense of how this might affect patient costs and the health care experience overall? Well, pharmacies in places like grocery stores, I mean, I remember that as a kid. Like, Osco was always part of Juul. Osco Juul was the big supermarket chain. So that doesn't feel very new to me. Um, but the, what does seem like a bigger deal in the last few years are entities like on the one hand, good RX, anyone who's not familiar with it.

16:13Uh, it's a basically a website, good RX.com and you tell them what you need and they'll tell you, Oh, we can get you a deal on that at your local pharmacy. We've present your, our coupon to them. And the trick with good RX is if you're using a good RX coupon, then you can't be using your insurance at the same time. So but maybe you're maybe good or is a better deal than your insurance or something or maybe you don't have good insurance or maybe your insurance has a giant deductible that includes drugs. And so you're not going to meet that deductible. So for a lot of people, a solution like good Rx can be helpful.

16:47And then Mark Cuban, entrepreneur everywhere, has started in the last couple of years what he calls cost plus drugs, where his promise is, I'm going to go find for your medicine, if it's generic, especially like wherever it's cheapest, I'm going to buy it from them. I'm going to market up 15 % and sell it to you that way. And, you know, what's interesting is I went looking it up and, you know, there's a prescription that I get for like 10 bucks a month. And I was like, yeah, it's a pretty good deal. Mark Cuban was saying, like, I'd sell it to you for$6.50.

17:21Wow. I don't think it's worth it. I think I'd pay him a few dollars for shipping, but, you know. When you have people like Mark Cuban getting in on this game, I mean, that speaks to the likelihood that there's a pinch point, that he's not alone in identifying. And maybe we should gaze into the crystal ball here for a second if that's possible. What do you see coming for CVS and Walgreens? Where does this go next, do you think? It's a good question. I don't really know. They have competition from places like GoodRx. And I think, you know, the presence of that competition means because GoodRx and Mark Cuban also make money, right?

17:58What they're understanding is that essentially there's so much price gouging in this space that there's room for someone to come in and undersell and still make money. I wish I thought that were better news for the rest of us because I just think like whoever gets big market share will take the most advantage of it they can and raise their prices to the highest point they can as long as they don't see somebody undercutting them at scale. Well, Dan, we've been talking about some really serious, heavy stuff. But before we let you go, I got to ask, when you go to pharmacy these days, what do you do to lift your spirits?

18:38You visit the candy aisle. You got a favorite that you pick up.

18:44We're going to need a lot of Skittles for this one. I mean, I don't think they have a very good deal on anything at the drugs or when I go there. I try to get everything I can someplace else. You know, in a pinch, because there is a Walgreens a few blocks from me. I'll be like, I'm out of shampoo. I guess I got to go to Walgreens and I'll pay what they charge me there. Yeah, the big, but puts a smile on my face. It's like, ah, we found a locally owned pharmacy that delivers. We call them and they deliver our stuff. Like, I'm still like, that's the win that I'm going to take. I mean, I'll just ride it as long as I can.

19:21Independent pharmacies, where we're going to be talking a whole lot more about those in just a moment. But we've been talking with Dan Weissman, host of An Arm and a Leg, co-produced by KFF Health News, exploring how much we pay for health care and why. Dan, thanks so much for joining us. Thanks for having me.

20:06years of experience securing global enterprises, Manage Engine can keep your business running safely, no matter how busy or hectic the world gets. This holiday, gift yourself and your business peace of mind. Visit cybersecurity.manageengine.com. That's cybersecurity.manageengine.com. This message is brought to you by Apple Card. Apple Card members can earn unlimited daily cash back on everyday purchases, wherever they shop. This means you could be earning daily cash on just about anything, like a slice of pizza from your local pizza place or a latte from the corner coffee shop. Apply for Apple Card in the Wallet app to see your credit limit offer in minutes.

20:55Subject to credit approval, Apple Card issued by Goldman Sachs Bank USA, Salt Lake City branch. terms and more at applecard.com.

21:10Hey, welcome back to Business Wars. You ever picked up that prescription from the pharmacy and been surprised by the price tag? It's a common experience in America and one that can feel like playing something of a game of roulette. Who's responsible? Well, you know about pharmacies, insurance companies, drug manufacturers themselves. Well, there's another influential party you may not have heard about. They're called Pharmacy Benefit Managers, or PBMs, and they play a major role in determining drug prices at pharmacies big and small. Here to shine a light on this side of the healthcare industry, Liz Tong, a reporter for WHYY's The Pulse.

21:49She recently took a deep dive into these PBMs on The Pulse, And she joins us now. Liz, welcome to Business Wars. Hi, thanks for having me. Before we get into what pharmacy benefit managers or PBMs actually are, I'd love to know how you came across this story. I mean, it's just not like PBMs are widely publicized or even known about, really. No, it was really a confluence of things. So I trawl a lot of social media groups and profiles dedicated to health care workers. and I started seeing PBMs popping up all over these groups. And in particular, there was a video by a physician named ZDoggMD. And I tried to go back and find it and I couldn't.

22:34But in this video, he was just railing against PBMs and talking about how they're these shadowy figures that have such an influence on drug prices and on patient care. And then around the same time, our host, Mikan, approached me and said that her neighborhood pharmacist had come to her and said, you know what you guys need to do a story about is PBMs. They are putting stores like mine out of business and somebody really needs to look into these guys. So it just kind of seemed like fate that it was time for us to look into PBMs. Yeah, that was why I was chuckling there. When all these things are pointing one direction, how do you ignore all these multiple tips?

23:17So give us a breakdown on what pharmacy benefit managers actually do? Where do they fit in? So their official definition is companies that manage prescription drug benefits, which sounds incredibly innocent and boring. But in reality, they are one of the most powerful players in the prescription drug market. And the way they got so powerful is because of this unique position they occupy in the prescription drug ecosystem, which is essentially that they're middlemen. They exist smack dab in the middle of this web of players, drug manufacturers, pharmacies, insurance companies, patients. And they're sort of like the hub for how money flows from one player to another.

24:07It is extremely confusing. When I was first researching PBMs, I tried to make like a flow chart to figure out how PBMs were related to each of these other players and to try and follow the flow of money. And I finally just gave up because it was so confusing. You can, by the way, find some pretty good flow charts online. But it's enough to say that they're basically like the money managers for the whole system. They process claims, they negotiate drug prices, they pay reimbursements to pharmacies, they help determine out-of-pocket costs. They have this whole bundle of middleman roles that they play.

24:48But the way that they advertise themselves, like their stated purpose is lowering costs for health plans and for consumers. Now, I want to pick up from there because maybe it's since most of us are coming from this, from the perspective of a patient, someone who goes to the pharmacy and they're picking up their prescription. And they're quite often surprised by the prices. It's my understanding that if you follow that line from the pickup window through the pharmacy, then and onto the manufacturer, right in between there, you're going to find the pharmacy benefit manager. And it's my understanding that that benefit manager is responsible for what?

Read the full transcript

25:31Coordinating the prices that the manufacturers charge to specific pharmacies, for example, that kind of thing? Yeah, you would think that there would be like a reasonably set price for a drug in the same way that like a pack of gum wouldn't be$1 at a CVS and like$20 at a Walgreens. But as a lot of people know, there is a ton of variation in drug prices. So why does this happen? Some of it has to do with the pharmacies themselves. They do have some leeway about how much they want to charge for a certain drug as long as it falls within a price range established by that patient's health plan, which is based on how much the health plan is paying for a given drug.

26:18And that number, how much insurance companies pay for medications, that is largely determined by PBMs. And so to understand how they got to that point, it's helpful to know a little bit about how PBMs came about and how they've evolved over time. In the late 1960s, there was a major expansion of prescription drug benefits. Before that happened, you would go into the pharmacy, pick up your prescription, pay the entire cost out of pocket, and then you would individually submit a claim to your insurance company for them to reimburse you directly. But once this expansion happened, once more people had prescription drug coverage and there were all of these new drugs being prescribed, insurance companies found that they were suddenly inundated with all of these small dollar value claims, and it was more than they could really handle.

27:18And so this was the need that the first PBMs, like the proto PBMs, were filling. They developed computerized systems that were installed at the pharmacies so patients could know right then and there whether a drug was covered and for how much and how much they'd have to pay out of pocket. And then it was the pharmacy that would be reimbursed by the insurance company via the PBM instead of the patient. So this was supposed to streamline the experience for consumers effectively, it sounds like, right? And reduce the price overall and make the pharmacy more competitive. Correct. But as the decades went by, the PPMs started to realize that they were uniquely positioned to do a lot more than just process claims and facilitate reimbursements.

28:07And they started positioning themselves as cost cutters. So they said to health insurers, hey, why don't you delegate the administration of your prescription drug benefits to us and we can do the same thing we did with processing claims. We can make it easier, more efficient and cheaper. And so as they developed over the 70s, 80s and 90s, they took on new functions. And one of the biggest and most consequential for them and for really the entire prescription drug market was they took over the development of formularies. And formularies are the list of drugs that health insurers are willing to cover.

28:48And so this ended up becoming a major bargaining chip where the PBMs could say, hey, drug manufacturer, if you give us a good price, we'll put you on our formulary. And at the same time, PBMs had also started forming these large patient networks, which gave them even more clout with the drug manufacturers, because now the PBMs are negotiating on behalf of this big pool of consumers who, again, the drug makers want access to. So it all sounds good in theory, But the problem is that these negotiations often end up distorting drug prices. So, for example, one of the big ways that PBMs secure savings is through rebates from drug manufacturers.

29:35Like for every$20 our patients spend on this drug that you make, you give us back$2. And then that money theoretically goes back into the pockets of the health plans and the consumers. But in order to afford these rebates, what has ended up happening is that manufacturers raise the list prices of their drugs. And as it turns out, the PBMs have no problem with that because higher prices mean higher rebates for them. And this is money in their pockets because it hasn't really been clear how much of these rebates is actually getting passed down to health plans and consumers. And so the result of all of this is that we're seeing those higher prices filtering down to the pharmacy counter.

30:26And then to add another layer or two of complexity, they're also doing secret negotiations with the insurers about how much they should be paying to reimburse the pharmacies for drugs. And then they're also doing negotiations with pharmacies about drug prices and how much they should be receiving for reimbursements, which means you end up with no standard price that everybody pays. You know, it's funny because I think we've all had the experience of going to a pharmacy and picking up a prescription. And it seems like the pharmacist or whoever is greeting you, the technician, can't give you a price for the medication.

31:09Yeah. It almost seems like they're just as surprised as you are. Yeah. So because PBMs are negotiating all of these different prices with manufacturers and cutting different deals with insurers and pharmacies, there isn't always a predictable cost to consumers. And there aren't always predictable reimbursements for the pharmacies either because PBMs use these secret formulas to determine not only drug prices, but also those reimbursements. But hands down, the biggest problem, especially for independence pharmacies, and I heard this again and again, is this practice called DIR fees or clawbacks, which is where the PBMs actually claw back some of the money that was supposed to go to the pharmacy for reimbursement.

32:01So, for example, say a pharmacy fills 5 ,000 prescriptions in a month for which they should be receiving$50 ,000 the next month. The pharmacy is counting on that$50 ,000 to pay for medications, to pay their workers, to pay rent and bills and whatever else. But when that check comes in the next month, instead of$50 ,000, it's only$35 ,000. And that is because the PBM is clawing back$15 ,000. And the reason they say they're doing this is because pharmacies have not been meeting certain performance metrics that were set up as part of an incentive program to encourage pharmacies to take good care of their patients, make sure they're adhering to their medications, stuff like that.

32:54And what makes this especially insidious is that these clawbacks are completely unpredictable. Pharmacies have no idea when they're going to happen. They have no idea how much money is going to be clawed back. And that makes it really hard to run a business because they don't know what their revenue is going to look like from month to month. I mean, in our series, we focused on Walgreens and CVS. And I know CVS got into the game by purchasing Caremark, which was an independent PBM. How's that played out for CBS? You would think that they would come out rather well in all this. So one of the interesting things that I found out talking to various people, including Douglas Hoy, he's the CEO of the National Community Pharmacists Association.

33:42He told me that chain pharmacies aren't immune from the effects of PBMs. They also suffer from clawbacks and some of the other practices that PBMs engage in. But if your parent company also owns a PBM, then it's not such a big deal because you're taking money out of one pocket, putting it in the other pocket. And so it's really... Sounds like quite the leg up on competition, doesn't it? Exactly. And that's one of the reasons that CVS Caremark has been getting some heat over the past two years, is because this vertical integration of CVS with its PBM creates a conflict of interest where, for example, CVS Caremark has engaged in practices to steer patients away from independent pharmacies or just away from other rival pharmacies in general and towards CVS pharmacies.

34:39We're even putting rival pharmacies out of business with some of these practices like clawbacks. Liz Tong is a reporter for WHYY's The Pulse. We're going to take a short break here. And when we return, we'll take a deeper look at the toll PBMs have taken on mom and pop pharmacists.

35:01As business owners and managers, you use software for your business every day. You use one piece of software to manage your customers, another to manage your employees, another to manage your finances, and the list goes on. You buy these pieces independently and hope they fit neatly together like a puzzle. and then you find out the hard way that they don't and you end up with a mess at the heart of your business operations. Does any of this sound familiar? Well, fortunately, Zoho offers a solution to this chaos. It's called Zoho One. Zoho One is a suite of around 50 pre-integrated business applications that fit together beautifully.

35:39So instead of dealing with disparate software from multiple vendors with multiple contracts and price points, You deal with one vendor, with all the pieces of the business software puzzle neatly put together, offered at a very attractive price. Now, if this sounds interesting to you, you gotta check out Zoho One at Zoho.one. That's Z-O-H-O dot O-N-E. With Zoho, you're not just licensing apps. You're licensing peace of mind. Let's say hypothetically, or maybe not so much, I'm developing a new podcast that needs an assistant producer, someone who knows how to brainstorm subjects to talk about. Find guests to bring in.

36:20That's a tall order. In other words, it's a job for Indeed Sponsored Jobs. Spend more time interviewing candidates who check all your boxes. And, you know, listeners of this show will get a$75 sponsored job credit to help you get your job the premium status it deserves at Indeed.com slash business wars. Just go to Indeed.com slash business wars right now and support our show by saying you heard about Indeed on this podcast. Indeed.com slash business wars. Terms and conditions apply. Hiring? Do it the right way with Indeed.

37:02Hi, welcome back to Business Wars. Our guest is Liz Tong, a reporter with The Pulse out of WHYY. She's been looking at the hidden forces that shape the cost of drugs for consumers and pharmacists, too, especially independent ones. Now, Liz, in the pharmacy world, there's almost a duopoly in terms of the major corporate players. You have CVS, you have Walgreens and not a whole lot in between. But there is a universe of independent pharmacies, too, that we've talked a little bit about. A lot of folks depend on that corner pharmacy across the U.S. Tell us more about what you've observed about these businesses.

37:37And I'm wondering if mom and pop pharmacies are more common than perhaps we think. So the number of independent pharmacies has decreased by almost 50 percent since 1980. and a lot of the ones that remain have been able to remain because they are collaborating with other independents and wholesalers. Have you ever been to one of these independent pharmacies yourself? I'm thinking you might have. I have. Yeah, there's not one in my neighborhood, but when I was first reporting, I did visit a couple of independent pharmacies. So what about the vibe? What was it like? Did you notice something right away that distinguished those smaller shops?

38:18The vibe was different. It felt less bland, I guess, less bland and industrial. It was easier to get the attention of the staff. You could see people chatting because they knew each other because they'd been going to this pharmacy for years. People love their neighborhood pharmacies. They are invested in their neighborhood pharmacies. and that's a huge difference for most of us in terms of what we experience with our local Walgreens or CVS. Is that their prime selling point? I'm trying to think about why would someone choose that over say a CVS or Walgreens, especially if the big players have a price advantage, do they?

39:06In some cases they do, but in a lot of cases they don't. A few years ago, Consumer Reports did a survey of independent and chain pharmacies to see how their drug prices compared. And what they found was a lot of variety. Independent pharmacies had both higher and lower prices for generics than chain pharmacies. And that's partly because independent pharmacies have the flexibility to price match in a way that chains don't. So it can really vary. How do they manage to do that, especially with all of these arrangements that pharmacy benefit managers, the big players in this sector, have come up with to try to optimize prices for everyone?

39:53I'm not sure how they're doing that. I mean, one answer is that fewer and fewer independent pharmacies are depending solely on or mostly even on drug reimbursements in order to survive. I talked to Douglas Hoy. He's the CEO of the National Community Pharmacists Association. And he told me that as PBMs have made reimbursements less dependable, more and more independents are turning to other sources of income. And mostly those are personalized services. So for example, special packaging, say for somebody who has arthritis and can't open a bottle and they need like punch out packaging. A lot of them work with nursing and long-term care facilities as sort of their like in-house pharmacy.

40:47They make money doing immunizations. They do something called compounding, which is where you customize medications. So say you've got a kid who can't swallow pills, you might make it into a form that's easier for kids to take. You mentioned how you spoke with one independent pharmacist about PBMs and the impact on his business. And we noticed he asked for anonymity. Why is that? Hmm. Yeah. It didn't start out that way, actually. When we first connected at the start of that eight months, he was completely on board. He was as helpful as he could be. He told me everything about what he had experienced and his background.

41:29And it wasn't until the very last minute I was fact checking with him and all of a sudden he got cold feet. And he just told me that he talked to his lawyer and his lawyer advised him not to allow us to move forward with a story. And so the fear he articulated was that people would be able to find out the name of his pharmacy by Googling his name. And by the way, he had already sold his pharmacy to new owners, which was part of what surprised me so much about his reluctance to go on the record. But he was afraid that this could hurt the new owners and draw negative attention from the PBMs. But I talked with Douglas Hoy about what exactly he was afraid of.

42:15And I was just looking back at this email. He said, the threat of retaliation is real. It's like the Chicago mob in the old days. The PBM can inflict pain in a lot of different ways that are hard to prove. They are judge, jury and executioner. So I kind of understood a little bit more after I talked with Douglas why he was afraid. And finally, after appealing to sort of his sense of duty in terms of letting people know about what PBMs are doing to independent pharmacies, he agreed. but only if we kept him anonymous. That's remarkable. Are PBMs really that powerful? Did he mention whether pharmacists at the bigger companies have similar concerns?

43:02I did hear from several of my experts that even these big chains aren't immune to the power and the whims of the PBMs. And not only them, drug manufacturers have also complained about PBMs. They are such a powerful player. I mean, we usually think of pharmaceutical companies, drug companies as being these huge monsters that have so much power and are so rich. And the fact that even they have had problems with PBMs was really kind of illuminating for me in terms of how much power they have. What about the PBMs themselves? What do they say about how they run things? So I did talk with a representative for PBM's group, the Pharmaceutical Care Management Association.

43:56That's their trade association. And I asked them mostly about this thing that is of biggest concern to independent pharmacies, these clawbacks. And there was total denial. For instance, one of the big claims about these clawbacks is that they are unpredictable. It's not clear. And the representative who I talked to said, well, the information's there. It's completely transparent. People just need to read their contracts. And of course, the people I talked to on the pharmacy side said, we have read the contracts and, you know, the information isn't there. But there was no admission that this was a problem.

44:43It was sort of just all blamed on the pharmacies and the groups that represent them. Liz, at the end of the day, what did you believe to be the takeaway about the impacts that PBMs have on pharmacies, big and small? My biggest takeaway was that they are an immensely powerful and largely malevolent force. And it was kind of unbelievable to me that they have managed to grow as powerful as they have, having started out as these little paper pushers, these administrative middlemen. But one of the encouraging things is that there does seem to be more attention that's being paid to PBMs and the problems that they are presenting, not only to pharmacies and pharmacists, but to us, the consumers, the patients, and to sort of the out of control drug spending.

45:46And so there's been some legislative packages that have been proposed to sort of rein in the PBMs, stop some of their worst practices, increase transparency. And when I talked with Douglas Hoy, he was concerned about, you know, some of the slowdowns that we've been seeing in Congress and how that could affect their ability to pass these legislative packages. And what he told me was, I'm just worried like with with this delay, are the PBMs going to be able to get to people before the votes happen? So it's a real question mark about what's going to happen next. But he did say that PBMs are almost certainly still going to be around for a while.

46:33Liz Tong is a reporter for WHYY's The Pulse covering health and science news. You can check out her reporting wherever you get your podcasts. Liz, thanks again for joining us. Thank you. Coming up on the best of Business Wars Daily, we're talking all about toys as we get into the industry's most important season.

46:57From Wondery, this is Episode 5 of CVS vs. Walgreens for Business Wars. I'm your host, David Brown. Kelly Kyle produced this episode. Peter Arcuni is our senior interview producer. Karen Lowe is our senior producer and editor. Edited and produced by Emily Frost. Sound design by Kyle Randall. Additional audio assistance by Sergio Enriquez. Dave Schelling is our producer. Our senior managing producer is Ryan Lohr. Matt Gant is our managing producer. Our executive producers are Jenny Lauer-Beckman and Marshall Louis for Wondering.

47:38I'm Indra Varma, and in the latest season of The Spy Who, we open the file on Oleg Gordievsky, the spy who outran the KGB. A rising star in the heart of Soviet power, Gordievsky is secretly feeding MI6, the Kremlin's deadliest secrets. For 11 years, he walked a razor's edge, exposing KGB threats that hastened the Cold War's end and helped prevent nuclear annihilation. But the KGB have a mole of their own. When they discover the truth, Gordievsky's world collapses. MI6 hatch a desperate, high-stakes plan to smuggle him out of Moscow. An escape that could rewrite history. Follow The Spy Who on the Wondery app or wherever you listen to podcasts or you can binge the full season of The Spy Who Outran the KGB early and ad-free with Wondery Plus

From the publisher

Between overworked pharmacists, healthcare consolidation, and rising drug costs, pharmacies are constantly having to adapt. Dan Weissmann, host of the An Arm and a Leg podcast, joins David to talk about how these conditions are affecting pharmacies — big and small — and consumers nationwide.  


Later, Liz Tung, a reporter for WHYY’s The Pulse, shares her deep dive into the mysterious world of pharmacy benefit managers, or PBMs. Her recent reporting examines how these entities hurt consumers and pharmacists alike, and what’s being done to challenge them. 

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

More from Business Wars

All 246 episodes
CVS vs. WalgreensBusiness Wars · 42 min
Listen in VO